Gonazon

Withdrawn

This medicine's authorisation has been withdrawn

azagly-nafarelin

Overview

The marketing authorisation for Gonazon has been withdrawn at the request of the marketing-authorisation holder.

Gonazon : EPAR - Summary for the public

Product information

Gonazon : EPAR - Product Information

Gonazon : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Gonazon
• Active substance:
  azagly-nafarelin
• International non-proprietary name (INN) or common name:
  azagly-nafarelin
• Species:
  • Dogs
  • Salmonidae (Salmonid fish)
• Anatomical therapeutic chemical veterinary (ATCvet) code:
  QH01CA

Pharmacotherapeutic group

Pituitary and hypothalamic hormones and analogues

Therapeutic indication

Female salmonid fish such as Atlantic salmon (Salmo salar), rainbow trout (Oncorhynchus mykiss), brown trout (Salmo trutta) and Arctic charr (Salvelinus alpinus)

Induction and synchronisation of ovulation for the production of eyed-eggs and fry.

Dogs (bitches)

Prevention of gonadal function in bitches via long term blockade of gonadotrophin synthesis.

Authorisation details

• EMA product number:
  EMEA/V/C/000075
• Marketing authorisation holder:
  Intervet International BV

  Intervet International B.V.; Wim de Körverstraat 35; 5831 AN Boxmeer; The Netherlands

• Marketing authorisation issued:
  20/07/2003
• Revision:
  7

Assessment history

Changes since initial authorisation of medicine

Gonazon : EPAR - Procedural steps taken and scientific information after authorisation

Initial marketing authorisation documents

Gonazon : EPAR - Procedural steps taken before authorisation

Gonazon : EPAR - Scientific Discussion